Emai£ºmarketing@medicilon.com.cn
ÓªÒµ×ÉѯרÏߣº400-780-8018
Tel: +1(781)535-1428(U.S. - West Coast)
0044 7790 816 954 (Europe)
Email: marketing@medicilon.com
µØµã£ºÉϺ£ÊÐÆÖ¶«ÐÂÇø´¨ºàáé585ºÅ
Óʱࣺ201299
µç»°£º+86 (21) 5859-1500£¨×Ü»ú£©
´«Õ棺+86 (21) 5859-6369
×èÖ¹±±¾©Ê±¼ä Êý¾ÝȪԴµÚÈý·½£¬½ö¹©²Î¿¼
ÏÖʵÐÅÏ¢Çë²Î¿¼£º¶«·½²Æ²úÍø
? 2023 ×ðÁú¿Ê± ±£´æËùÓÐȨÁ¦ »¦ICP±¸10216606ºÅ-3
»¦¹«Íø°²±¸ 31011502018888ºÅ | ÍøÕ¾µØͼ
ÓªÒµ×Éѯ
Öйú£º
Email: marketing@medicilon.com.cn
ÓªÒµ×ÉѯרÏߣº400-780-8018
£¨½öÏÞ·þÎñ×Éѯ£¬ÆäËûÊÂÒËÇ벦´ò´¨É³×ܲ¿µç»°£©
´¨É³×ܲ¿µç»°: +86 (21) 5859-1500
ÍâÑó£º
+1(781)535-1428(U.S.)
0044 7790 816 954 (Europe)
Email:marketing@medicilon.com
¹ú¼ÊÌÛʹѧ»á£¨The International Association for the Study of Pain, IASP£©ÓÚ2020ÄêÐû²¼ÁËIASPÌØÊâר¼Ò×é¶ÔÌÛÍ´µÄ×îнç˵£ºÌÛÍ´ÊÇÒ»ÖÖÓëÏÖʵ»òDZÔÚµÄ×éÖ¯ËðÉËÏà¹ØµÄ²»Óä¿ìµÄ¸ÐÊܺÍÇéÐ÷ÇéÐ÷ÌåÑ飬»òÓë´ËÏàËƵÄÂÄÀú¡£ÕâÖØнç˵Á˶ÔÌÛÍ´µÄÑо¿¡¢ÁÙ´²ÆÀ¹À¡¢Õï¶Ï¡¢ÖÎÁƺÍÖÎÀí£¬¶ÔÈËÃǶÔÈâÌåºÍ¾«ÉñÍ´¿àµÄÊìϤ¾ßÓÐÖ¸µ¼ÒâÒå¡£
Ö»¹ÜÈËÀàÒÑÔÚ¼²²¡»úÖƵÄÑо¿ÉÏÈ¡µÃÁËÖØ´óÏ£Íû£¬µ«ÌÛÍ´ÒÀ¾ÉÊÇÑÏÖصÄÁÙ´²ÎÊÌâ¡£ÏÖÓÐÖÎÁÆÊÖ¶ÎÎÞ·¨ÍêÈ«Öª×㻺½âÌÛÍ´µÄÐèÇ󣬶øÒ©Îï¿ÉÄܵ¼ÖµIJ»Á¼·´Ó¦»áΪ»¼Õß´øÀ´²î±ðˮƽµÄΣÏÕ¡£ÎªÁËïÔÌÒ©Î︱×÷Óá¢ÔöǿҩЧ¡¢ÑÓÉì°ëË¥ÆÚ£¬¸÷´óÖÆÒ©¹«Ë¾ºÍ¿ÆÑÐְԱһֱͶÈë´ó×ڵľ«ÉñºÍ²ÆÁ¦Ñз¢ÐÂÒ©£¬ÒÔÆÚ¸üºÃµÄÔ츣ÈËÀà¡£
Ä¿½ñÁÙ´²¶ÔÌÛÍ´µÄ³£¼û·ÖÀàÈçÏ£º
£¨1£©ÒÀ¾ÝÒ»Á¬Ê±¼ä¿É·ÖΪ¼±ÐÔºÍÂýÐÔ£»
£¨2£©ÒÀ¾Ý±¬·¢Ôµ¹ÊÔÓÉ¿É·ÖΪ´´ÉËÐÔ¡¢Ñ×Ö¢ÐÔ¡¢Éñ¾ÐԵȣ»
£¨3£©ÒÀ¾ÝÊÜËðÉñ¾¿É·ÖΪÖÜΧÉñ¾Í´»òÖÐÊàÉñ¾Í´¡£
ÔÚÁÙ´²Ç°Ñо¿½×¶Î£¬Ó¦»ùÓÚ¶ÔÁÙ´²¼²²¡ÌåÏֺͲ¡ÀíµÄÃ÷È·£¬Õë¶Ô²î±ð¼²²¡»úÖƽ鵼ϵÄÌÛÍ´ÌåÏÖ½¨ÉèÏìÓ¦¶¯ÎïÄ£×Ó£¬Ê¹ÓúÏÀíµÄÐÐΪÕÉÁ¿ÒªÁìÕë¶ÔÐÔÆÀ¹À£¬²¢Ñо¿ÆäÐÄÀí¡¢¼¤ËØ¡¢Éú»¯ºÍÐÐΪ¸Ä±ä¡£
ÕòʹҩЧÆÀ¼ÛÄ£×ÓÖ¼ÔÚÄ£Äâ²î±ðµÄÁÙ´²¼²²¡£¬Ñо¿ÆäDZÔÚ»úÖƺÍÖÎÁÆÒªÁ죬²¢ÕÉÁ¿Äܹ»ÆÀ¹ÀÌÛÍ´ÌåÑéµÄ¶à¸ö»·½Ú£¬°üÀ¨·´ÉäÐÔÍ´¾õ¹ýÃôÕÉÁ¿¡¢ÌÛÍ´µÄ¸ÐÊܺÍÇéÐ÷ά¶ÈÒÔ¼°ÌÛÍ´¶Ô¹¦Ð§ºÍÉúÑÄÖÊÁ¿µÄÓ°ÏìµÈ¡£
Äö³Ý¶¯ÎïµÄÌÛÍ´Ä£×Ó[1]
ÏÖÔÚ£¬×ðÁú¿Ê±Òѽ¨ÉèÁ˼±ÐÔÌÛÍ´¡¢Ñ×Ö¢ÐÔÌÛÍ´ºÍÉñ¾ÐÔÌÛÍ´µÄÄ£×Ó£¬²¢¿ª·¢Á˶àÖÖÓÕµ¼ÓëÁÙ´²ÌÛÍ´×ÛºÏÕ÷Ïà¹ØµÄÖÖÖÖÌÛÍ´±íÐ͵ij£ÓÃÒªÁ죬ÒÔ¼°ÆÀ¹ÀÌÛÍ´µÄÖ÷ÒªÐÐΪ²âÊÔÒªÁì¡£ÕâЩģ×Ó¾ùÒÑͨ¹ýÑéÖ¤ÇÒÄÜÓÐÓõزâÊÔºòÑ¡Ò©Îï¡£
ÈÈ°åÊÔÑéÊÇÒ»ÖÖÆÕ±éÓÃÓÚÄö³Ý¶¯ÎïÍ´¾õÆÀ¹ÀµÄÊÔÑéÒªÁì¡£½«Äö³Ý¶¯Îï·ÅÔÚÒ»¸öÓò£Á§ÈÝÆ÷¹Ø±ÕµÄÈÈ°åÉÏ£¬¼Í¼ËüÃÇ×ö³ö·´Ó¦£¨Èç·¢Éù¡¢Ìòצ×Ó»ò¾ÙÆðצ×Ó£¬¶à½ÓÄÉÌò×ã×÷Ϊʹ·´Ó¦Ö¸±ê£©ËùÐèµÄʱ¼ä£¬¼´µÃ³ö¶ÔÈÈÏà¹ØÌÛÍ´×÷³ö·´Ó¦µÄDZÔÚÆÚ¡£
ÈÈ°å·´Ó¦ÓиßλÖÐÊà¼ÓÈ룬¸ÃÊÔÑéµÄÓŵãÊǿ͹ۡ¢¿ÉÁ¿»¯¡¢¿ÉÖظ´¾ÙÐÐÇÒ²»»áÒýÆðÑ×Ö¢£¬Äܹ»ÉîÈëÏàʶÌÛÍ´·´Ó¦ºÍÌÛÍ´ÄÍÊÜÐÔµÄˮƽ£¬ÊʺÏÆÀ¹ÀСÊóÖ«ÌåÔ˶¯µÄ·´Ï죬ÉÏƤ²ã×éÖ¯¶ÔÓк¦´Ì¼¤µÄ·´Ó¦µÈ¡£
×ðÁú¿Ê±°¸Àý£ºÈÈ°åÊÔÑé
ŤÌåÊÔÑéÊÇÒ»ÖÖͨ¹ý»¯Ñ§´Ì¼¤ÓÕ׿±ÐÔÑ×Ö¢ÐÔÌÛÍ´µÄÒªÁì¡£ÏòСÊó¸¹Ç»×¢Éä´Ì¼¤ÐÔÎïÖÊ£¨Èç±½õ«¡¢»º¼¤ëÄ¡¢ÒÒËáµÈ£©ÓÕ·¢ÌÛÍ´£¬ÊӲ첢¼Í¼ʵÑ鶯ÎïµÄŤÌå·´Ó¦£¬À´ÆÀ¹ÀÍâÖÜÕòÍ´Ò©ÎïµÄÁÆЧ£¨Koster et al., 1959£©¡£
¸ÃÒªÁì²Ù×÷ÇáÓ¯¡¢Ãô¸Ð¡¢Öظ´ÐԺ㬳£ÓÃÓÚÆÀ¼ÛÖÐÊàºÍÍâÖÜÕòÍ´Ò©Îï¡£
×ðÁú¿Ê±°¸Àý£º´×ËáŤÌåÊÔÑé
¸£¶ûÂíÁÖÊÔÑé±»ÆÕ±éÓ¦ÓÃÓÚÑо¿»¯Ñ§´Ì¼¤ÓÕ׿±ÐÔºÍÒ»Á¬ÐÔÌÛÍ´¡£Äö³Ý¶¯ÎïµÄ¸£¶ûÂíÁÖÊÔÑéÊÇÒ»ÖÖÓÐÓÿɿ¿µÄÍ´¾õÄ£×Ó£¬¶ÔÖÖÖÖÕòÍ´Ò©ÎﶼºÜÃô¸Ð¡£ÔÚÄö³Ý¶¯Îïºóצ¾Æ¤ÏÂ×¢É丣¶ûÂíÁÖÈÜÒº£¬ÓÕ·¢ÓëŨ¶È³ÉÕý±ÈµÄÌÛÍ´·´Ó¦£¬¿ÉÌåÏÖΪÁ½¸öʱÏà¡£
? IÏࣺÔÚ×¢É丣¶ûÂíÁÖºóÁ¬Ã¦±¬·¢¼±ÐÔ·´Ó¦£¬Ö±½Ó¼¤»îÁ˳õ¼¶´«Èë¸ÐÊÜÉñ¾Ôª£¬¿ÉÒ»Á¬Ô¼5~10·ÖÖÓ¡£IÏàÌÛÍ´Ö÷ÒªÊǴ̼¤CÏËάËùÖ£¬·ÇçÞÌåÀ࿹Ñ×Ò©¶ÔÆäûÓÐ×÷Óã»
? IIÏࣺÄܹ»·´Ó¦´«Èë±³½ÇÄÚÖÐÊàÉñ¾ÏµÍ³Éñ¾ÔªÃô»¯µÄ×ÛºÏЧӦ£¬¿ÉÔÚ×¢ÉäºóµÄ10~60·ÖÖÓ×óÓÒÒ»Á¬±¬·¢¡£IIÏàÌÛÍ´·´Ó¦ÓÐÑ×Ö¢»úÖƼÓÈ룬Éñ¾ÐÔÕòÍ´Ò©ºÍ·ÇçÞÌ忹Ñ×Ò©¶Ô¸Ã½×¶ÎÌÛÍ´·´Ó¦¶¼ÓÐÕòÍ´×÷Óá£
ÓëÆäËûÄ£×ÓÏà±È£¬¸£¶ûÂíÁÖÄ£×ÓʵÑé¾ßÓÐÒÔÏÂÓÅÊÆ£º¸£¶ûÂíÁÖ×¢ÉäºóÁ¬Ã¦ÒýÆðCÏËά×Ô¾õÔ˶¯¾çÔö£¬¾¿ìËÙת´ïÖ¼¹ËèͶÉäÉñ¾Ôª£¬¼ÌÒÔµÚ¶þÏà´«È뱬·¢£¬·´Ó¦ÎªÆձ鱳½ÇÉñ¾Ôª¼¤»î£¬Òý·¢ÌÛÍ´¡£¸Ã´Ì¼¤¿ÉÒ»Á¬ÓÕµ¼¶¯Îﱬ·¢Í´¾õÐÐΪ£¬¶ø·ÇÔÚ²»ÊÜÔ¼ÊøµÄ¶¯ÎïÉíÉϱ¬·¢Ë²Ê±Í´¾õÐÐΪ£¬¿ÉÒÔ¸ü׼ȷµØÆÀ¹ÀÕòÍ´¼ÁµÄÆðЧʱ¼äºÍÒ»Á¬Ê±¼ä£¬»¹¿ÉÒÔÇø·ÖÖÐÊàÐÔÕòÍ´¼ÁºÍÑ×Ö¢ÐÔÕòÍ´¼Á¡£
×ðÁú¿Ê±°¸Àý£º¸£¶ûÂíÁÖÖÂÍ´Ä£×Ó
ÍêÈ«¸¥ÊÏ×ô¼Á£¨Complete Freund's Adjuvant, CFA£©ÊÇÒ»ÖÖϸ¾ú¿¹ÔÈ黯¼Á£¬¿ÉÓÕµ¼Ï¸°û½éµ¼µÄÃâÒßÓ¦´ð£¬Ôö½øÃâÒßÇòÂѰ׵ı¬·¢£¬ÒýÆð×¢É䲿λµÄ×éÖ¯Ñ×Ö¢ºÍϸ°ûÒò×ÓÊÍ·Å¡£CFAÄÜÄ£ÄâÀà·çʪÐÔÊàŦÑ×µÈÑ×Ö¢ÐÔ²¡±ä£¬ÇÒÔÚ´óÊóºÍСÊóÖоù¾ßÓкܸߵÄÖØÏÖÐÔ¡£CFAº¬ÓÐÖ¬ÂѰס¢ÌÇÖ¬ºÍëľÛÌÇ£¬¿É±»¿¹Ô³ÊµÝϸ°ûͨ¹ýģʽʶ±ðÊÜÌåʶ±ð¡£CFA¿ÉÓÕµ¼ÍâÖܺÍÖÐÊàµÄÍ´¾õÉñ¾ÔªµÄÃô»¯£¬´Ó¶øµ¼ÖÂÌÛÍ´Ö¢×´¡£ÀýÈç¶ÔÈȴ̼¤ºÍ»úе´Ì¼¤µÄÍ´¾õ¹ýÃôºÍÒ춯֢¡£
CFAÓÕµ¼µÄÍâÖÜÑ×Ö¢ÐÔÌÛÍ´Ä£×ӻᱬ·¢Ò»ÖÖÒ»Á¬ÐÔÑ×֢״̬£¬¿ÉÓÃÓÚÑо¿ÂýÐÔÑ×Ö¢ÐÔÌÛÍ´µÄDZÔÚ»úÖÆ¡£
×ðÁú¿Ê±°¸Àý£ºCFAÖÂÍ´Ä£×Ó
Àà·çʪÐÔÊàŦÑ×£¨Rheumatoid Arthritis, RA£©ÊÇ×î³£¼ûµÄÂýÐÔÑ×Ö¢ÐÔ¼²²¡Ö®Ò»£¬ÌØÕ÷ÊÇÂýÐÔÊàŦÑ×Ö¢¡¢»¬Ä¤·Êºñ¡¢Èí¹ÇºÍ¹ÇÖÊÖð½¥ÆÆË𣬵¼ÖÂÊàŦÌÛÍ´ÉõÖÁÑÏÖزм²¡£ÁÙ´²Ö¢×´°üÀ¨ÊàŦÌÛÍ´ºÍÔ˶¯ÄÑÌâ,¶Ô»¼ÕßµÄÉúÑĺÍÊÂÇéÔì³É¸ºÃæÓ°Ï죬²¢Òý·¢ÐÄÀíÎÊÌâ¡£RAµÄ¶¯ÎïÄ£×Ó¹ØÓÚÑо¿ÌåÄÚ·¢²¡»úÖƺÍÈ·¶¨¿¹RAÒ©ÎïµÄÁÆЧÖÁ¹ØÖ÷Òª¡£
ÔÚÒÑÍù¼¸Ê®ÄêÖУ¬Ðí¶àÄö³ÝÀදÎïÊàŦÑ×Ä£×ÓÒѱ»ÆÀ¹ÀΪDZÔÚ¿¹RAÒ©ÎïÆÀ¼ÛµÄÄ£×Ó£¬½¨Ä£ÒªÁìÒ²Ïà¶Ô³ÉÊì¡£ÆäÖУ¬½ºÔÓÕµ¼µÄÊàŦÑ×£¨Collagen Induced Arthritis, CIA£©ºÍRAÔÚÁÙ´²Ç°¡¢²¡ÀíѧºÍÃâÒßѧµÈ·½ÃæµÄÏàËÆÐÔ£¬Ê¹Æä³ÉΪÑо¿ºÍÓ¦ÓÃ×îÆÕ±éµÄ±ê׼ģ×Ó¡£ÔÚCIAÄ£×ÓÖУ¬ÊàŦÑ×µÄÉú³¤ºÍÑÏÖØˮƽͨ¹ý»ùÓÚÍâÖÜÊàŦÖ×Õͺͷ¢ºìµÄÁÙ´²ÆÀ·ÖϵͳÀ´ÆÀ¹À£¬ÆäÌÛÍ´·´Ó¦Ò²ÊÇÆäÖ÷ÒªÖ¢×´Ö®Ò»¡£
×ðÁú¿Ê±°¸Àý£ºCIAÊàŦÑ×ÌÛÍ´Ä£×Ó
ÖÜΧÉñ¾²¡ÀíÐÔÌÛÍ´ÊÇÒ»ÖÖÑÏÖصÄÂýÐÔÌÛÍ´£¬Ö²¡ÒòËضàÑù£¬ÔÚ²î±ð²¿Î»¡¢²î±ðʱ¼ä¡¢²î±ð¼²²¡×´Ì¬ÏÂÌåÏÖ³ö¶àÖÖ²î±ðµÄ»úÖÆ¡£
×ø¹ÇÉñ¾·Ö֧ѡÔñÐÔËðÉË£¨Sciatic Nerve Injury, SNI£©Ä£×ÓÊÇÔÚÄö³ÝÀදÎïµÄ×ø¹ÇÉñ¾¸ß´¦½áÔú£¬Ä£ÄâÍâÖÜÉñ¾²¡ÀíÐÔÌÛÍ´µÄÖ¢×´£¬ÆÀ¹À×÷ÓÃÓÚÍâÖÜÉñ¾Í´µÄÕòÍ´Ò©Îï¡£
×ðÁú¿Ê±°¸Àý£º×ø¹ÇÉñ¾·Ö֧ѡÔñÐÔËðÉË£¨SNI£©Ä£×Ó
ÊõºóÌÛÍ´£¨Postoperative Pain, POP£©ÊÇÒ»ÖÖ¼±ÐÔΣÏÕÐÔÌÛÍ´¡£ÕâÖÖ¶ÌÔݵ«Ç¿ÁÒµÄÌÛÍ´²»µ«»áÑÏÖØÏ÷Èõ»¼ÕßµÄÐж¯ÄÜÁ¦²¢ÑÓ»º¿µ¸´£¬ÈçδÄÜʵʱ¿ØÖÆ£¬»¹¿ÉÄÜÉú³¤ÎªÊõºóÂýÐÔÌÛÍ´(Chronic Post-surgical Pain, CPSP)£¬ÆäÐÔ×ÓÒ²¿ÉÄÜת±äΪÉñ¾²¡ÀíÐÔÌÛÍ´»ò»ìÏýÐÔÌÛÍ´¡£
°¢Æ¬ÀàÒ©ÎïÊÇÏÖÔÚÕë¶ÔPOPµÄÖ÷ÒªÖÎÁÆÊֶΣ¬µ«¼øÓÚÆä³Éñ«ÐÔ£¬¼±Ðè¸ü¶à·Ç°¢Æ¬ÀàÌÛÍ´ÖÎÁÆÒ©Îï½øÈëÁÙ´²¡£ÎªÁË¿ª·¢ÖÎÁÆPOPµÄ×î¼ÑÁÆ·¨²¢½µµÍCPSPµÄÑÏÖØˮƽºÍ/»ò±¬·¢ÂÊ£¬±ØÐèÃ÷È·Æä¼²²¡»úÖÆ¡£
ÔÚÁÙ´²Ç°Ñо¿½×¶Î£¬POPµÄ»Æ½ð±ê×¼ÊÇ×ãµ×ÇпÚÄ£×Ó£¨Brennan et al.,1996£©£¬²¢Í¨¹ýVon Frey·¨²âÊÔÇпÚÊõºóµÄÍ´¾õÐÐΪ¡£´óÊóºÍСÊó¼±ÐÔÇпÚÍ´Ä£×Ó¾ù¿ÉÓ¦ÓÃÓÚÑо¿µ¼ÖÂÊõºóÌÛÍ´µÄ·Ö×Ó¡¢Ï¸°ûºÍÐÄÀí»úÖÆ£¬²¢ÎªÆäÐÂÒ©µÄÑз¢Ìṩ¿É¿¿µÄÆÀ¼ÛÒªÁì¡£
×ðÁú¿Ê±°¸Àý£ºÇпÚÌÛÍ´Ä£×Ó
ÌÇÄò²¡ÊÇÒ»ÖÖÒÔ¸ßѪÌÇΪÌØÕ÷µÄ´úлÐÔ¼²²¡£¬ÌÇÄò²¡ÖÜΧÉñ¾²¡±ä£¨Diabetic Peripheral Neuropathy, DPN£©ÔòÊÇÌÇÄò²¡×î³£¼ûµÄÂýÐÔ²¢·¢Ö¢Ö®Ò»¡£DPNµÄÌØÕ÷ÊÇÖÜΧÉñ¾´ÓÔ¶¶Ëµ½½ü¶ËÖð½¥ÍË»¯£¬´Ó¶øµ¼Ö¸ÐÊÜÖ¢×´µÄÒì³££¬°üÀ¨ÌÛÍ´¡¢ÐéÈõºÍ/»ò¸ÐÊÜËðʧ¡£½¨ÉèºÏÊʵÄÌåÄÚÑо¿Ä£×Ó¹ØÓÚÑо¿DPN²¡Àí»úÖƺͿª·¢ÐµÄÖÎÁÆÕ½ÂÔÖÁ¹ØÖ÷Òª¡£¡¤
ÔÚÄö³ÝÀදÎïÖн¨ÉèÌÇÄò²¡Éñ¾²¡±äÄ£×ÓµÄÈýÖÖÖ÷ÒªÕ½ÂÔΪ£º»¯Ñ§ÓÕµ¼¡¢ÓªÑøÓÕµ¼ºÍÒÅ´«ÐÞÊΡ£ÏÖÔÚ£¬²¿·ÖÌÇÄò²¡´óÊóºÍСÊóÄ£×ÓÄܹ»ÊӲ쵽ÓëDPNÏà¹ØµÄÉñ¾ËðÉË¡£
×ðÁú¿Ê±°¸Àý£ºÌÇÄò²¡Éñ¾Í´Ä£×Ó
»¯ÁÆÓÕµ¼µÄÖÜΧÉñ¾²¡±ä£¨Chemotherapy-induced Painful Neuropathy, CIPN£©Êdz£¼ûÇÒÑÏÖصÄÁÙ´²ÎÊÌ⣬Æäˮƽ¼°Ô¤ºóÓëµ¥´ÎºÍÀÛ»ýÒ©Îï¼ÁÁ¿Óйأ¬³£¼ûÓÚʹÓû¯ÁÆÒ©ÎïÖÎÁƺó£¨È粬ÀàÒ©Îï¡¢³¤´º¼îÀà¡¢×Ïɼ´¼ÀࡢɳÀû¶È°·¡¢ÂÑ°×øÌåÒÖÖƼÁºÍ±íÝìõ«ÀàÒ©Î¡£ÖÜΧÉñ¾²¡ÀíÐÔÌÛÍ´ÊÇÖ÷Òª¸±×÷ÓÃÖ®Ò»£¬¿É·ºÆðÂéľ¡¢´ÌÍ´¡¢Ò»Á¬/×Ô¾õÌÛÍ´¡¢¶Ô»úеºÍ/»òÀä´Ì¼¤¹ýÃôµÈÖ¢×´¡£
ͨ¹ýÖظ´×¢É仯ÁÆÒ©Î°üÀ¨×Ïɼ´¼¡¢³¤´ºÐ¼îµÈ£©£¬¿ÉÒÔÔÚÄö³Ý¶¯ÎïÉíÉÏÔÙÏÖÀàËÆÓÚÈËÀ໯ÁÆÔì³ÉµÄÌÛÍ´ÐÐΪ£¬´Ó¶ø½¨ÉèCIPNµÄÄö³Ý¶¯ÎïÄ£×Ó¡£ÓÕµ¼µÄÉñ¾²¡±äÌåÏÖΪ½ÏµÍµÄ»úеʹãÐÖµ¡¢ÀäÃô¸ÐÐÔÒÔ¼°Ðµ÷ÐÔÇå¾²ºâÄÜÁ¦Ï½µ¡£
×ðÁú¿Ê±°¸Àý£º»¯ÁÆÍ´Ä£×Ó
[1] Adriana Dom¨ªnguez-Oliva, et al. The neurobiology of pain and facial movements in rodents: Clinical applications and current research. Front Vet Sci. 2022 Sep 29:9:1016720. doi: 10.3389/fvets.2022.1016720.
[2] Amanda Gunn, et al. The influence of non-nociceptive factors on hot-plate latency in rats. J Pain. 2011 Feb;12(2):222-7. doi: 10.1016/j.jpain.2010.06.011.
[3] Colleen R McNamara, et al. TRPA1 mediates formalin-induced pain. Proc Natl Acad Sci U S A. 2007 Aug 14;104(33):13525-30. doi: 10.1073/pnas.0705924104.
[4] Carlos Minoru Omura, et al. Decrease of IL-1¦Â and TNF in the Spinal Cord Mediates Analgesia Produced by Ankle Joint Mobilization in Complete Freund Adjuvant-Induced Inflammation Mice Model. Front Physiol. 2022 Jan 14:12:816624. doi: 10.3389/fphys. 2021.816624.
[5] Anne-Laure Mausset-Bonnefont, et al. Arthritis sensory and motor scale: predicting functional deficits from the clinical score in collagen-induced arthritis. Arthritis Res Ther. 2019 Dec 4;21(1):264. doi: 10.1186/s13075-019-2047-z.
[6] Ashley M Cowie, et al. A Mouse Model of Postoperative Pain. Bio Protoc. 2019 Jan 20;9(2): e3140. doi: 10.21769/BioProtoc.3140.
[7] Phillipe D O'Brien, et al. Mouse models of diabetic neuropathy. ILAR J. 2014;54(3):259-72. doi: 10.1093/ilar/ilt052.
[8] Holly L Hopkins, et al. Chemotherapy-induced painful neuropathy: pain-like behaviours in rodent models and their response to commonly used analgesics. Curr Opin Support Palliat Care. 2016 Jun;10(2):119-128. doi: 10.1097/SPC.0000000000000204.
×ðÁú¿Ê±Ò©Ð§²¿½ô¸úÐÐÒµÉú³¤ÓëÊг¡ÐèÇó£¬Ò»Ö±ÍêÉÆÁ¢Ò죬¾¶àÄêÂÄÀúÀÛ»ý£¬¶à·½ÑéÖ¤ºÍºã¾Ãʵ¼ùÄ¥Á·£¬½¨ÉèÁËÍêÉƵĶ¯ÎïÄ£×ӿ⣬¿Éƾ֤¿Í»§ÐèÇóÌṩºÍ¶¨ÖÆÖÖÖÖÓÐÓõĶ¯ÎïÄ£×Ó£¬¼ì²âÒ©ÎïµÄÓÐÓÃÐÔ¡£ÊµÑ鶯ÎïÓзÇÈËÁ鳤ÀදÎȮ¡¢¾ÞϸÊó¡¢Íá¢ëàÊó¡¢Ð¡ÐÍÖíµÈÖÖÀà¡£
¾ÓÉ20ÄêµÄ³Áµí»ýÀÛ£¬Ò©Ð§²¿Òѽ¨ÉèÁè¼Ý230¸ö·ÇÖ×Áö¼²²¡Ò©Ð§ÆÀ¼ÛÄ£×Ó£¬ÆäÁìÓòº¸ÇÁËÉñ¾¾«Éñϵͳ¡¢ÐÄÄÔѪ¹Üϵͳ¡¢Ïû»¯ÏµÍ³¡¢Ñ×Ö¢ÃâÒßϵͳ¡¢ÄÚÉø͸¼°´úлϵͳ¡¢ÑۿƼ°ÆäËûµÈÈÈÃż²²¡ÁìÓò¡£
ҩЧ²¿·Ö¾ß±¸ÓµÓÐÉîֿרҵÀíÂÛ֪ʶºÍ¶àÄêʵÑéÂÄÀúµÄרҵÍŶӣ¬¾ß±¸ÖÜÈ«ÆÀ¼ÛÖÖÖÖÖÖ±ðÐÂҩҩЧµÄ´ó²¿·ÖÏȽøʵÑéÉèÊ©£¬¿É´Ó·Ö×Óˮƽ¡¢Ï¸°ûˮƽ¡¢ex-vivo¡¢in vivoµÄ¶àÌõÀí£¬ÖÜÈ«ÆÀ¼Û´Ó³ÉÒ©ÐÔµ½Ò»ÀàÁ¢ÒìÒ©µÄÖÖÖÖÀàÐÍÐÂÒ©µÄÒ©ÀíҩЧ¡£¿É¶ÔС·Ö×Ó»¯Ò©¡¢ADCÒ©Îϸ°ûÖƼÁ¡¢µ¥¿¹¡¢ÖÐÒ©µÈ¶àÖÖÀà±ðµÄÒ©Îï¾ÙÐÐÁÙ´²Ç°µÄϵͳҩЧÆÀ¼Û£¨°üÀ¨¿Ú·þÖƼÁ¡¢×¢Éä¼Á¡¢¾Ö²¿ÍâÓÃÖƼÁ¡¢µÎ±Ç¼Á¡¢ÅçÎí¼ÁµÈ£©£¬ÎªÐÂÒ©É걨ÌṩÖÜÈ«ÕæʵµÄÊÔÑé×ÊÁϼ°Ñо¿±¨¸æ¡£ÖÁ½ñÒÑÊܵ½ÖÚ¶àÒµÄÚ¿Í»§µÄ¸ß¶ÈÈÏ¿É¡£